G6PC2 Down (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with G6PC2 Down.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with G6PC2 Down.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with G6PC2 Down.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with G6PC2 Down.

Results found

Linked to

 

Label

Description

 

Gene

ENSG00000157873 - TNF receptor superfamily member 14

Gene

ENSG00000069943 - phosphatidylinositol glycan anchor biosynthesis class B

Gene

ENSG00000158560 - dynein cytoplasmic 1 intermediate chain 1

Gene

ENSG00000122873 - CDGSH iron sulfur domain 1

Gene

ENSG00000077498 - tyrosinase

Gene

ENSG00000087116 - ADAM metallopeptidase with thrombospondin type 1 motif 2

Gene

ENSG00000169562 - gap junction protein beta 1

Gene

ENSG00000130656 - hemoglobin subunit zeta

  • Gene

    ENSG00000157873 - TNF receptor superfamily member 14


  • Gene

    ENSG00000069943 - phosphatidylinositol glycan anchor biosynthesis class B


  • Gene

    ENSG00000158560 - dynein cytoplasmic 1 intermediate chain 1


  • Gene

    ENSG00000122873 - CDGSH iron sulfur domain 1


  • Gene

    ENSG00000077498 - tyrosinase


  • Gene

    ENSG00000087116 - ADAM metallopeptidase with thrombospondin type 1 motif 2


  • Gene

    ENSG00000169562 - gap junction protein beta 1


  • Gene

    ENSG00000130656 - hemoglobin subunit zeta

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.